C O M M U N I C A T I O N S
Figure 5. Sugar analogue 10 and spirocyclic compound 11 showing bonds
(boxed) that match side chain CR-Câ vectors in 6S and 6R, respectively.
Figure 3. Superimposition of the 30 lowest-energy calculated NMR
structures for 6S (left, backbone RMSD 0.053 Å) and 6R (right, RMSD
0.047 Å) in DMSO. White dashes indicate hydrogen bonds.
tidic templates, including sugars and spirocyclic compounds (Figure
5), found in natural products. For example, CR-Câ atoms of 6S
superimposed well (RMSD ) 0.40 Å over eight atom pairs) on
the indicated bonds (boxed) of carbohydrate 10, which did not
match nearly so well to 6R (1.07 Å) or 7 (0.59 Å). On the otherhand
6R superimposed well on the indicated bonds (boxed) of the
tricyclic spiro-compound 11 (RMSD 0.51 Å), which did not match
so well to 6S or 7 (RMSDs 1.08, 1.20 Å). Thus CTPs with a
â-amino acid could provide a useful link between protein archi-
tecture and nonpeptidic molecules. Libraries of such CTPs may be
useful screening tools to rapidly identify pharmacophore space that
can then be computer-matched to nonpeptidic structures.
Thus selective incorporation of a â-amino acid can make CTPs
easier to synthesize, more resistant to hydrolysis, conformationally
homogeneous, and more useful as chiral scaffolds that can be
derived from protein sequence alone. These advantages may expand
the utility of CTPs as pharmacophoric probes which mimic both
protein turns and natural products.
Figure 4. Superposition of X-ray structure of 7 (yellow)7 on (a, left):
modeled 8 (orange) and 9 (pink); (b, right): 6S from Figure 3 (blue, RMSD:
0.55 Å (4 CR-Câ vectors), 0.48 Å (12 common backbone atoms)).
ROEs, for 6R (30 ROE distance restraints: 14 intraresidue, 14
sequential, 2 medium range, and 2 φ-angle restraints: âhPhe φ
-120 ( 30°, Asu φ -120 ( 30°) and for 6S (32 ROE distance
restraints: 20 intraresidue, 10 sequential, 2 medium range, and 1
φ-restraint: âhPhe φ -120 ( 30°) using a dynamic simulated
annealing and energy minimization protocol in XPLOR.5 Initial
structures indicated a likely H-bond in both 6R (Asu NH‚‚‚OC
âhPhe) and 6S (Asu NH‚‚‚OC Phe), consistent with VT-NMR data
(Figure 2).
Acknowledgment. We thank ARC for financial support.
Supporting Information Available: Syntheses, structures, char-
acterization data for 4-6 (PDF). This material is available free of charge
The H-bond restraints improved structural convergence (Figure
3), well-defined backbones being consistent with stabilization by
four trans-amides, D-proline, a trans-annular H-bond and steric
constraints imposed by the 13-membered ring. The backbones and
three side-chain projections (âhPhe, Phe, R-Pro) were similar for
6R and 6S, the epimeric Asu side chain being directed into or above
the plane of the cycle, respectively. φ-Angles agreed with measured
3JNHCHR constants. (Supporting Information).
6S is homologous to bioactive CTPs such as chlamydocin (7),
HC toxin (8), and trapoxin B (9).2,3 Modeled6 structures for 7-9
(Figure 4a) and structures in CDCl33 for 7 and 8 have two γ-turns
and a backbone conformation very similar to those of 6S (Figure
4b). Inserting a methylene into the 12-membered ring rotates the
Asu-âhPhe amide bond in 6, preventing formation of one of the
γ-turn H-bonds and redirecting the CR-Câ vector at âhPhe.
Inversion of stereochemistry at Asu causes the Pro CO to rotate
69° in 6R relative to 6S (Figure 3), restoring a gauche relationship
between the Pro carbonyl and the CR-Câ vector of Asu, permitting
a â turn-defining Asu NH‚‚‚OC âhPhe H-bond.
References
(1) (a) Cavelier-Frontin, F.; Pe`pe, G.; Verducci, J.; Siri, D.; Jacquier, R. J.
Am. Chem. Soc. 1992, 114, 8885. (b) Shute, R. E.; Kawai, M.; Rich, D.
H. Tetrahedron 1998, 44, 685.
(2) (a) Hirota, A.; Suzuki, A.; Suzuki, H.; Tamura, S. Agric. Biol. Chem.
1973, 37, 643. (b) Singh, S. B.; Zink, D. L.; Liesch, J. M.; Mosley, R. T.;
Dombrowski, A. W.; Bills, G. F.; Darkin-Rattray, S. J.; Schmatz, D. M.;
Goetz, M. A. J. Org. Chem. 2002, 67, 815. (c) Itazaki, H.; Nagashima,
K.; Sugita, K.; Yoshida, H.; Kawamura, Y.; Yasuda, Y.; Matsumoto, K.;
Ishii, K.; Uotani, N.; Nakai, H.; Terui, A.; Yoshimatsu, S.; Ikenishi, Y.;
Nakagawa, Y. J. Antibiotics 1990, 43, 1524. (d) Tani, H.; Fujii, Y.;
Hiromitsu, N. Phytochemistry 2001, 58, 305. (e) Pringle, R. B. Plant
Physiol. 1972, 48, 756.
(3) (a) Kawai, M.; Pottorf, R. S.; Rich, D. H. J. Med. Chem. 1986, 29, 2409.
(b) Kawai, M.; Jasensky, R. D.; Rich, D. J. Am. Chem. Soc. 1983, 105,
4456. (c) Mascagni, P.; Pope, M.; Gibbons, W. A. Biochem. Biophys.
Res. Commun. 1983, 113, 10.
(4) Kessler, H. Angew. Chem., Int. Ed. Engl. 1982, 21, 512.
(5) (a) Bru¨nger, A. T. X-PLOR Manual, Version 3.1; 1992, Yale University:
New Haven, CT. (b) Nilges, M.; Gronenborn, A. M.; Bru¨nger, A. T.;
Clore, G. M. Protein Eng. 1988, 2, 27. (c) Brooks, B. R.; Bruccoleri, R.
E.; Olafson, B. D.; States, D. J.; Swaminathan, S.; Karplus, M. J. Comput.
Chem. 1983, 4, 187.
(6) MacroModel: Mohamadi, F.; Richards, N. G. J.; Guida, W. C.; Kiskamp,
R.; Lipton, M.; Caufield, C.; Chang, G.; Hendrickson, T.; Still, W. C. J.
Comput. Chem. 1990, 112, 440-447.
(7) Flippen, J.; Karle, I. L. Biopolymers 1976, 15, 1081.
(8) (a) Greene, J.; Kahn, S.; Savoj, H, Sprague, P.; Teig, S. J. Chem. Inf.
Comput. Sci. 1994, 34, 1297-1308. (b) Catalyst, Release 4.7; Accelrys
Inc.: San Diego, 2002.
To illustrate the potential of 13-membered CTPs as peptidomi-
metic scaffolds, the four CR-Câ vectors of 6S and 6R (Figure 3)
were used as constraints to search for matching compounds in the
Interbioscreen database with Catalyst.8 Their unique side-chain
projections matched a structurally diverse range of useful nonpep-
JA029205T
9
J. AM. CHEM. SOC. VOL. 125, NO. 3, 2003 641